Skip to main content
SpringerLink
Log in

Autoimmune liver disease and malignancy

  • Chapter
Immunology and Liver

Part of the book series: Falk Symposium ((FASS,volume 114))

  • 120 Accesses

Abstract

Primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC), and chronic autoimmune hepatitis represent the vast majority of autoimmune liver diseases. An increased prevalence of extrahepatic autoimmune manifestations, such as Raynaud’s phenomenon, Sjögren’s syndrome, autoimmune thyroiditis and inflammatory bowel disease (IBD), are present in all these disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Mellmkjaer L, Andersen V, Linet M, Gridley G, Hoover R, Olsen J. Non-Hodgkin lymphoma and other cancers among a cohort of patients with systemic lupus erythematosus. Arthritis Rheum. 1997;40:761–768.

    Article  Google Scholar 

  2. Mellemkjar L, Linet M, Gridley G, Frisch M, Mööler H, Olsen J. yRheumatoid arthritis and cancer risk. Eur J Cancer. 1996;32A: 1753–1757.

    Article  Google Scholar 

  3. Bassendine M. Aetiological factors in hepatocellular carcinoma. Ballières Clin Gastroenterol. 1987;1:1–16.

    Article  CAS  Google Scholar 

  4. Colombo M, De Franchis R, Ninno D et al. Hepatocellular carcinoma in Italian patients with cirrhosis. Engl J Med. 1991;325:675–680.

    Article  CAS  Google Scholar 

  5. De Bac C, Stroffolini T, Gaeta G, Taliani G, Giusti G. Pathogenic factors in cirrhosis with and without hepatocellular carcinoma. Hepatology. 1994;201:1225–1230.

    Article  Google Scholar 

  6. Kaczynski J, Hansson G, Hermodsson S, Olsson R, Wallerstedt S. Minor role of hepatitis B and C infection in the etiology of hepatocellular carcinoma in low-endemic area. Scand J Gastroenterol. 1996;31:809–813.

    Article  CAS  PubMed  Google Scholar 

  7. Krasner N, Johnson P, Portmann B, Watkinson G, Macsween R, Williams R. Hepatocellular carcinoma in primary biliary cirrhosis: report of four cases. Gut. 1979;20:255–258.

    Article  CAS  PubMed  Google Scholar 

  8. Melia W, Johnson P, Neuberger J, Zaman S, Portmann B, Williams R. Hepatocellular carcinoma in primary biliary cirrhosis: detection by alpha-fetoprotein estimation. Gastroenterology. 1984;87:660–703.

    CAS  PubMed  Google Scholar 

  9. Jones D, Metcalf J, Collier J, Bassendine M, James O. Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes. Hepatology. 1997;26:1148–1152.

    Article  Google Scholar 

  10. Gluskin L, Guariglia P, Payne J, Banner B, Economou P. Hepatocellular carcinoma in a patient with precirrhotic primary biliary cirrhosis. J Clin Gastroenterol. 1985;7:441–444.

    Article  CAS  PubMed  Google Scholar 

  11. Nakanuma Y, Terada T, Doishita K, Miwa A. Hepatocellular carcinoma in primary biliary cirrhosis: an autopsy study. Hepatology. 1990;11:1010–1016.

    Article  CAS  PubMed  Google Scholar 

  12. Löö f, Adami H-O, Sparén P-O et al. Cancer risk in primary biliary cirrhosis: a population-based study from Sweden. Hepatology. 1994;20:101–104.

    Google Scholar 

  13. Johnson P, Krasner N, Portmann B, Eddlestone A, Williams R. Hepatocellular carcinoma in Great Britain: influence of age, sex, HBsAg status and aetiology of underlying cirrhosis. Gut. 1978;198:1022–1026.

    Article  Google Scholar 

  14. Floreani A, Biagini M, Chiaramonte M, Milani S, Naccarato R, Surrenti C. Incidence of hepatic and extra-hepatic malignancies in primary biliary cirrhosis. Ital J Gastroenterol. 1991;23:523–524.

    Google Scholar 

  15. Van Dam G, Gips C. Primary biliary cirrhosis in the Netherlands. Scand J Gastroenterol. 1997;32:77–83.

    Article  PubMed  Google Scholar 

  16. Turissini S, Kaplan M. Hepatocellular carcinoma in primary biliary cirrhosis. Am J Gastroenterol. 1997;92:676–678.

    CAS  PubMed  Google Scholar 

  17. Terris G, Lande P, Vaury P. Carcinome hépatocellulaire et cirrhosis biliaire primitive: une nouvelle observation. Gastroenterol Clin Biol. 1982;6:593–594.

    CAS  PubMed  Google Scholar 

  18. Wakai T, Shirai T, Tsukada K, Aono T, Kurosaki I. Hepatocellular carcinoma associated with precirrhotic primary biliary cirrhosis successfully treated by a right hepatic lobectomy: report of a case. Surg Today. 1996;26:723–726.

    Article  CAS  PubMed  Google Scholar 

  19. Floreani A, Baragiotta A, Baldo V, Menegon T, Farinati F, Naccarato R. Hepatic and extrahepatic malignancies in primary biliary cirrhosis. Hepatology. 1999 (In press).

    Google Scholar 

  20. Farinati F, Floreani A, De Maria N, Fagiouli S, Naccarato R, Chiaramonte M. Hepatocellular carcinoma in primary biliary cirrhosis. J Hepatol. 1994;21:315–316.

    Article  CAS  PubMed  Google Scholar 

  21. Imada J, Hoshino H, Nishimura D et al. Case report: Multiple cancers: hepatocellular carcinoma and adenocarcinomas of the common bile duct and the gall bladder in a woman with primary biliary cirrhosis. J Gastroenterol Hepatol. 1996;11:546–550.

    Article  CAS  PubMed  Google Scholar 

  22. Wolke A, Schaffner A, Kapelman B, Sacks H. Malignancy in primary biliary cirrhosis: high incidence of breast cancer in affected women. Am J Med. 1084;76:1075–1078.

    Article  Google Scholar 

  23. Sherlock S, Heathcote J. Primary Biliary Cirrhosis, (2nd edn.) Oxford: Oxford University Press, 1999. (Bircher J, ed. Oxford Textbook of Clinical Hepatology, vol. 2).

    Google Scholar 

  24. Kaplan M. Primary biliary cirrhosis. Engl J Med. 1996;335:1570–1580.

    Article  CAS  Google Scholar 

  25. Kruize A, Hené R, Van der Heide A et al. Long term follow-up of patients with Sjögren’s syndrome. Arthritis Rheum. 1996;39:297–303.

    Article  CAS  PubMed  Google Scholar 

  26. Parker R, Kendall E. The liver in ulcerative colitis. Br Med J. 1954;2:1030–1032.

    Article  CAS  PubMed  Google Scholar 

  27. Converse C, Reagan J, DeCosse J. Ulcerative colitis and carcinoma of the bile ducts. Am J Surg. 1971;121:39–45.

    Article  CAS  PubMed  Google Scholar 

  28. Broome U, Olsson R, Lööf L et al Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut. 1996;38:610–615.

    Article  CAS  PubMed  Google Scholar 

  29. Rosen C, Nagorney D, Wiesner R, Coffey R, LaRusso L. Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg. 1991;213:21–25.

    Article  CAS  PubMed  Google Scholar 

  30. La Russo N, Wiesner R, Ludwig J. Sclerosing Cholangitis, (2nd edn.) Oxford: Oxford University Press, 1999. (Bircher J, ed. Oxford Textbook of Clinical Hepatology, vol. 2).

    Google Scholar 

  31. Bergquist A, Glaumann H, Persson B, Broomé U. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis-a case control study. Hepatology. 1998;27:311–316.

    Article  CAS  PubMed  Google Scholar 

  32. Kaczynski J, Hansson G, Wallerstedt S. Incidence, etiologic aspects and clinicopathologic features in intrahepatic cholangiocellular carcinoma. Acta Oncol. 1998;37:77–83.

    Article  CAS  PubMed  Google Scholar 

  33. Wiesner R, Poryako M, LaRusso N, Steers J, Krom R, Dickson E. Liver transplantation for primary sclerosing cholangitis: impact of risk factors and outcome. Liver Transplant Surg. 1996;2:99–108.

    Article  CAS  Google Scholar 

  34. Goss J, Shackleton C, Farmer D et al Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single experience. Ann Surg. 1997;225:472–483.

    Article  CAS  PubMed  Google Scholar 

  35. Dorudi S, Chapman R, Kettlewell M. Carcinoma of the gallbladder in ulcerative colitis and primary sclerosing cholangitis. Report of two cases. Dis Colon Rectum. 1991;34:827–828.

    Article  CAS  PubMed  Google Scholar 

  36. Miros M, Kerlin P, Walker N, Harper J, Lynch S, Strong R. Predicting cholangiocarcinoma in patients with primary sclerosing cholangitis before transplantation. Gut. 1991;32:1369–1373.

    Article  CAS  PubMed  Google Scholar 

  37. Nashan B, Schlitt H, Tusch G et al Biliary malignancies in primary sclerosing cholangitis: timing for liver transplantation. Hepatology. 1996;23:1105–1111.

    Article  CAS  PubMed  Google Scholar 

  38. Farley D, Weaver A, Nagourney D. ‘Natural history’ of unresected cholangiocarcinoma: patient outcome after noncurative resection. Mayo Clin Proc. 1995;70:425–429.

    Article  CAS  PubMed  Google Scholar 

  39. Campbell W, Ferris J, Holbert B, Thaete F, Baron R. Biliary tract carcinoma complicating primary sclerosing cholangitis: evaluation with CT, cholangiography, US and MR imaging. Radiology. 1998;207:41–50.

    CAS  PubMed  Google Scholar 

  40. Rizzi P, Ryder S, Portmann B, Ramage J, Naoumov N, Williams R. p53 Protein overexpression in cholangiocarcinoma arising in primary sclerosing cholangitis. Gut. 1996;38:265–268.

    Article  CAS  PubMed  Google Scholar 

  41. Bergquist A, Glaumann H, Stål P, Wang G-S, Broomé U. Apoptosis and bile duct cell dysplasia in patients with primary sclerosing cholangitis with and without cholangiocarcinoma. J Hepatol. 1998;28: abstract P/C07/001.

    Google Scholar 

  42. Mansfield J, Griffin S, Wadehra V, Matthewson K. A prospective evaluation of cytology from biliary strictures. Gut. 1997;40:671–677.

    CAS  PubMed  Google Scholar 

  43. Rabinovitz M, Zajko A, Hassanein T et al Diagnostic value of brush cytology in the diagnosis of bile duct carcinoma; a study in 65 patients with bile duct strictures. Hepatology. 1990;12:747–752.

    Article  CAS  PubMed  Google Scholar 

  44. Sears R, Duckworth C, Decaestecker C et al Image cytometry as a discriminatory tool for cytologic specimens obtained by endoscopic retrograde cholangiopancreatography. Cancer Cytopathol. 1998;84:119–126.

    Article  CAS  Google Scholar 

  45. Ramage J, Donaghy A, Farrant J, Iorns R, Williams R. Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology. 1995;108:865–869.

    Article  CAS  PubMed  Google Scholar 

  46. Hultcrantz R, Olsson R, Danielsson Å et al A 3-year prospective study on serum tumor markers used for detecting cholangiocarcinoma in patients with primary sclerosing cholangitis. J Hepatol. 1999;30:669–673.

    Article  CAS  PubMed  Google Scholar 

  47. Keiding S, Hansen S, Rasmussen H et al Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography. Hepatology. 1998;28:700–706.

    Article  CAS  PubMed  Google Scholar 

  48. Celli A, Que F. Dysregulation of apoptosis in the cholangiopathies and cholangiocarcinoma. Sem Liver Dis. 1998;18:177–185.

    Article  CAS  Google Scholar 

  49. Khan Z, Neugut A, Ahsan H, Chabot JA. Risk factors for biliary tract cancers. Am J Gastroenterol. 1999;94:149–152.

    Article  CAS  PubMed  Google Scholar 

  50. Yu M, Hsu F, Sheen I et al Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers. Am J Epidemiol. 1997;145:1039–1047.

    Article  CAS  PubMed  Google Scholar 

  51. Brentnall T, Hagitt R, Rabinovitch P et al Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology. 1996; 110:331–338.

    Article  CAS  PubMed  Google Scholar 

  52. Broomé U, Löfberg R, Veress B, Eriksson S. Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential. Hepatology. 1995;22:1404–1408.

    PubMed  Google Scholar 

  53. Martins E, Fleming K, Garrido M, Hine K, Chapman R. Superficial thrombophlebitis, dysplasia, and cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology. 1994; 107:537–542.

    CAS  PubMed  Google Scholar 

  54. Ludwig J, Wahlström H, Batts K, Wiesner R. Papillary bile duct dysplasia in primary sclerosing cholangitis. Gastroenterology. 1992;102:2134–2138.

    CAS  PubMed  Google Scholar 

  55. Fleming K, Clausen O, Glaumann H, Bergquist A, Smith D. Biliary dysplasia in primary sclerosing cholangitis as a marker of increased risk of cholangiocarcinoma. Hepatology. 1998;28:A1136.

    Google Scholar 

  56. Ismail T, Angrisani L, Hübscher S, McMaster P. Hepatocellular carcinoma complicating primary sclerosing cholangitis. Br J Surg. 1991;78:360–361.

    Article  CAS  PubMed  Google Scholar 

  57. Harnois D, Gores G, Ludwig J, Steers J, LaRusso N, Wiesner R. Are patients with cirrhotic stage primary sclerosing cholangitis at risk for the development of hepatocellular cancer? J Hepatol. 1997;27:512–516.

    Article  CAS  PubMed  Google Scholar 

  58. Snook J, Kelly P, Chapman R. Fibrolamellar hepatocellular carcinoma complicating ulcerative colitis with primary sclerosing cholangitis. Gut. 1989;30:243–245.

    Article  CAS  PubMed  Google Scholar 

  59. Bansal P, Sonnenberg A. Risk factors of colorectal cancer in inflammatory bowel disease. Am J Gastroenterol. 1996;91:44–48.

    CAS  PubMed  Google Scholar 

  60. Marchesa P, Lashner BA, Lavery I et al. The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol. 1997;92:1285–1288.

    CAS  PubMed  Google Scholar 

  61. Kornfelt D, Ekbom A, Ihre T. Is there an excess risk for colorectal cancer in ulcerative colitis patients with primary sclerosing cholangitis? A population-based study. Gut. 1997;41:518–521.

    Article  Google Scholar 

  62. Leidenius M, Farkkila M, Karkkainen P et al Colorectal dysplasia and carcinoma in patients with ulcerative colitis and primary sclerosing cholangitis. Scand J Gastroenterol. 1997;32:706.

    Article  CAS  PubMed  Google Scholar 

  63. Loftus E, Sandborn W, Tremaine W et al. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis. Gastroenterology. 1996;110:432–440.

    Article  PubMed  Google Scholar 

  64. Nuako K, Ahlqvist D, Sandborn W et al. Primary sclerosing cholangitis and colorectal carcinoma in patients with chronic ulcerative colitis: a case control study. Cancer. 1998;82:822–826.

    Article  CAS  PubMed  Google Scholar 

  65. Nagengast F, Grubben M, vanMunster I. Role of bile acids in colorectal carcinogenesis. Eur J Cancer. 1995;31:1067–1070.

    Article  Google Scholar 

  66. Lundqvist K, Broomé U. Differences in colonic disease activity in patients with ulcerative colitis with and without primary sclerosing cholangitis. Dis Colon Rectum. 1997;40:541–546.

    Article  Google Scholar 

  67. Bleday R, Lee E, Jessurun J et al. Increased risk of early colorectal neoplasms after hepatic transplant in patients with inflammatory bowel disease. Dis Colon Rectum. 1993;36:908.

    Article  CAS  PubMed  Google Scholar 

  68. Burroughs A, Bassendine M, Thomas H, Sherlock S. Primary liver cell cancer in autoimmune chronic liver disease. Br Med J. 1981;282:2–73.

    Article  Google Scholar 

Download references

Authors
  1. U. Broomé
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Bergquist
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Abt. Gastroenterologie/Hepatologie Zentrum Innere Medizin, Medizinische Hochscule Hannover, Carl-Neuberg Str. 1, D-30625, Hannover, Germany

    M. P. Manns

  2. Medizinische Klinik II, Klinikum Grosshadern der LMU München, Marchioninistr. 15, D-81377, München, Germany

    G. Paumgartner

  3. Abt. Gastroenterologie Zentrum der Innere Medizin, Klinikum der Johann-Wolfgang-Goethe-Universität Frankfurt, Theodor-Stern-Kai 7, D-60596, Frankfurt, Germany

    U. Leuschner

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Broomé, U., Bergquist, A. (2000). Autoimmune liver disease and malignancy. In: Manns, M.P., Paumgartner, G., Leuschner, U. (eds) Immunology and Liver. Falk Symposium, vol 114. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-4000-3_26

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-4000-3_26

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-5768-4

  • Online ISBN: 978-94-011-4000-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation